Xerox hits a paper jam with its HP takeover bid

HP has turned down a $33bn bid from rival Xerox, insisting it is worth more. But a merger seems likely before too long. Matthew Partridge reports.

HP Inc Announces It Will Cut 9,000 Jobs Over 3 Years In Restructuring Plan

HP should be buying Xerox, not vice versa
(Image credit: 2019 Getty Images)

HP's board has "unanimously" decided to reject a $33bn $22-a-share bid from rival Xerox, on the grounds that it "significantly undervalues" the computer hardware giant, says Mark Vandevelde in the Financial Times. At the same time, HP's board has indicated that the door "remains open" to "a potential combination" of the two companies, demanding "more information about Xerox's business prospects and the scale of any potential synergies". In making the bid for HP, which involves a mixture of cash and shares, the office equipment provider has been trying to capitalise on a rally in its shares, which have climbed by 47% in a year.

One prominent supporter of the $33bn proposed merger between the two companies is activist investor Carl Icahn, who owns 10.6% of Xerox (worth $2.9bn) and 4.2% (worth $1.2bn) of HP, says James Dean in The Times. Icahn considers a deal a "no-brainer", believing "very strongly" that there is scope for synergies between HP, best known for home printers, and Xerox, which manufactures larger machines for firms. He argues that companies in shrinking industries tend to decline "much more slowly" than many market participants may predict and may also continue to generate "substantial" amounts of cash.

Not so fast, says Dan Gallagher in The Wall Street Journal. Most of the money offered by Xerox would have come in cash, "which in turn would primarily be financed by borrowing". This would have turned Xerox into "a heavily indebted enterprise that would need to slash costs aggressively".

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

What's more, Xerox's claim that the company could have saved $1.5bn from combining research and development (R&D) is debatable, given that both of them spent a combined total of only $1.8bn on R&D in their last full years. Still, HP "may not be able to say no forever" as investors in both firms "are clearly intrigued by the idea of a combination".

A different approach?

Provoking HP into making a bid for Xerox "may have been Xerox's plan all along", says Alex Webb on Bloomberg. The companies have been in tentative talks "about bulking up several times". But while Xerox looks "to have at least succeeded in bringing HP back to the negotiating table", HP's low debt means that it still has other alternatives, including buying back its own shares. The best solution may be for a merger that involves stock rather than cash, with shareholders benefiting from any "uplift".

Dr Matthew Partridge

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.

As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.

Follow Matthew on Twitter: @DrMatthewPartri